1. Abifadel M, Rabes JP, Boileau C et al. (2007). After the LDL receptor and apolipoprotein B, autosomal dominant hypercholesterolemia reveals its third protagonist: PCSK9. In Annales d'endocrinologie (Vol. 68, No. 2–3, pp. 138–146). Abifadel, M., Rabès, J. P., Devillers, M.,. (2009). Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol.
2. metabolism and disease. Hum Mutat, 30(4), 520–9.
3. A systematic review of major cardiovascular risk factors: a growing Global Health concern;Adhikary D;Cureus,2022
4. Relationships between genetic polymorphisms of E670G in PCSK9 gene and coronary artery disease: a meta-analysis;Adi D;Int J Clin Exp Med,2015
5. Serum PCSK9 levels, but not PCSK9 polymorphisms, are associated with CAD risk and lipid profiles in southern Chinese Han population;Cai G;Lipids Health Dis,2018